Online citations, reference lists, and bibliographies.
← Back to Search

Correction To: Can Early Palliative Care With Anticancer Treatment Improve Overall Survival And Patient-related Outcomes In Advanced Lung Cancer Patients? A Review Of The Literature

M. Ambroggi, C. Biasini, Ilaria Toscani, E. Orlandi, R. Bertè, Martina Mazzari, L. Cavanna
Published 2018 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The original version of this article unfortunately incorrectly captured the title for Table 2.
This paper references
10.1089/JPM.2005.8.1025
Interval between palliative care referral and death among patients treated at a comprehensive cancer center.
W. Cheng (2005)
10.1089/JPM.2006.0257
Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center.
F. Braiteh (2007)
10.1016/j.jpainsymman.2016.01.003
Integrated Onco-Palliative Care Associated With Prolonged Survival Compared to Standard Care for Patients With Advanced Lung Cancer: A Retrospective Review.
J. King (2016)
10.1016/S0140-6736(15)01281-7
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
R. Herbst (2016)
10.1016/S0885-3924(01)00406-7
Do hospital-based palliative teams improve care for patients or families at the end of life?
I. Higginson (2002)
The problem of caring for the dying in a general hospital; the palliative care unit as a possible solution.
B. Mount (1976)
10.1056/NEJMoa0810699
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
T. Mok (2009)
10.1371/journal.pmed.1000100
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
A. Liberati (2009)
10.1016/S0140-6736(13)62416-2
Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
C. Zimmermann (2014)
10.1089/jpm.2009.0166
Discharge outcomes and survival of patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center.
D. Hui (2010)
10.1056/NEJMoa1214886
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
A. Shaw (2013)
10.1002/cncr.24942
Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center
D. Hui (2010)
10.1016/S0885-3924(02)00599-7
Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers?
I. Higginson (2003)
10.5301/tj.5000593
Position Paper of the Italian Association of Medical Oncology on Early Palliative Care in Oncology Practice (Simultaneous Care)
V. Zagonel (2017)
10.1001/jama.300.14.1665
Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment.
A. Wright (2008)
10.1200/JCO.2010.29.5618
Integrating supportive and palliative care in the trajectory of cancer: establishing goals and models of care.
E. Bruera (2010)
10.1089/109662101750290191
Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: a prospective study using the Lung Cancer Symptom Scale in a community hospital.
S. Lutz (2001)
10.1016/j.jpainsymman.2008.09.011
Late referrals to palliative care units in Japan: nationwide follow-up survey and effects of palliative care team involvement after the Cancer Control Act.
T. Morita (2009)
10.1038/bjc.1995.124
Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party.
P. Hopwood (1995)
10.1056/NEJMoa1408440
First-line crizotinib versus chemotherapy in ALK-positive lung cancer.
B. Solomon (2014)
10.1634/theoncologist.2015-0110
Distance as a Barrier to Cancer Diagnosis and Treatment: Review of the Literature.
M. Ambroggi (2015)
10.1089/jpm.2007.0103
Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer center.
B. Osta (2008)
10.1002/cncr.25389
Timing of palliative care referral and symptom burden in phase 1 cancer patients
D. Hui (2010)
10.1200/JCO.2008.19.6543
The role of investigational therapy in management of patients with advanced metastatic malignancy.
E. Freireich (2009)
10.1089/109662102753641331
Palliative care models: international perspective.
E. Bruera (2002)
10.1200/JCO.2005.12.107
Late referrals to specialized palliative care service in Japan.
T. Morita (2005)
10.1089/JPM.2006.9.391
Symptom control in palliative care--Part I: oncology as a paradigmatic example.
S. Dalal (2006)
10.1200/JCO.2016.70.5046
Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial.
J. Temel (2017)
10.1200/JCO.2000.18.4.893
Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data.
Penny Hopwood (2000)
10.22605/RRH1146
Disparity in cancer survival between urban and rural patients--how can clinicians help reduce it?
S. Sabesan (2009)
10.1097/SPC.0b013e328325a5ab
The assessment and management of family distress during palliative care
T. Zaider (2009)
10.1056/NEJMoa1507643
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
H. Borghaei (2015)
10.1001/jama.2010.258
Availability and integration of palliative care at US cancer centers.
D. Hui (2010)
10.1016/J.JPAINSYMMAN.2003.10.011
Impact of a half-day multidisciplinary symptom control and palliative care outpatient clinic in a comprehensive cancer center on recommendations, symptom intensity, and patient satisfaction: a retrospective descriptive study.
F. Strasser (2004)
10.1200/JCO.2006.09.2627
Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients.
J. Temel (2007)
10.3322/caac.20006
Cancer Statistics, 2009
A. Jemal (2009)
10.1007/s00520-016-3278-z
Impact of early palliative interventions on the outcomes of care for patients with non-small cell lung cancer
C. Nieder (2016)
10.1056/NEJMoa1000678
Early palliative care for patients with metastatic non-small-cell lung cancer.
J. Temel (2010)
10.1200/JCO.2012.43.9422
MET as a possible target for non-small-cell lung cancer.
A. Sadiq (2013)
10.1002/cncr.24206
Supportive versus palliative care: What's in a name?
N. Fadul (2009)
10.1200/JCO.2014.58.3302
Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.
J. Mazieres (2015)
10.1017/S1478951509000108
The project ENABLE II randomized controlled trial to improve palliative care for rural patients with advanced cancer: baseline findings, methodological challenges, and solutions.
Marie Bakitas (2009)
10.1056/NEJMoa1504627
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
J. Brahmer (2015)
10.1016/S1470-2045(11)70393-X
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
R. Rosell (2012)



This paper is referenced by
10.5388/AON.2018.18.4.198
Comparison of Life-Sustaining Treatment in Terminal Cancer Patients between a Cancer and Hospice Unit after Do-Not-Resuscitate Orders
E. J. Nam (2018)
10.1016/j.lungcan.2019.10.002
Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer.
M. Perol (2019)
10.1007/s11864-020-0702-x
How Effective Is Palliative Care in Improving Patient Outcomes?
Sarah Milazzo (2020)
10.1016/j.bulcan.2019.11.011
Intensity of care, expenditure, place and cause of death people with lung cancer in the year before their death: A French population based study.
A. Tanguy-Melac (2020)
10.1007/978-981-15-2521-6_12
Palliative Care and End-of-Life Issues
Connie Chu (2020)
10.1186/s12904-020-00568-3
Evaluation of a communication skills training to facilitate addressing palliative care related topics in advanced cancer patients: study protocol of a multicenter randomized controlled trial (PALLI-KOM)
N. Harnischfeger (2020)
10.1016/j.jgo.2018.09.003
Multidisciplinary care in the hematology clinic: Implementation of geriatric oncology.
V. Goede (2019)
10.1136/bmjopen-2019-035673
Electronic symptom monitoring in patients with metastatic lung cancer: a feasibility study
R. B. Friis (2020)
10.1016/j.jvir.2020.06.007
Combination of Bronchial Arterial Infusion Chemotherapy plus Drug-Eluting Embolic Transarterial Chemoembolization for Treatment of Advanced Lung Cancer-A Retrospective Analysis of 23 Patients.
Yanwei Zeng (2020)
10.1371/journal.pone.0226597
Does early palliative identification improve the use of palliative care services?
N. Mittmann (2020)
10.5301/tj.5000593
Position Paper of the Italian Association of Medical Oncology on Early Palliative Care in Oncology Practice (Simultaneous Care)
V. Zagonel (2017)
10.2147/PROM.S238009
Illness Perceptions and Quality of Life in Patients with Non-Small-Cell Lung Cancer: A 3-Month Follow-Up Pilot Study
M. Vollmann (2020)
Semantic Scholar Logo Some data provided by SemanticScholar